In addition, GDC-0623 treatment resulted in an insignificant reduction of tumor vascularization and F4/80+ cell infiltration in p-LKO B16F10 tumors, but a significant reduction of tumor infiltration with CD45+ cells (Supplemental Figure 10, L–N). The gene discussed is PTPRC; the disease is neoplasm.